Education
About Us
Working with TipRanks
Follow Us
PRXV - ETF AI Analysis
Top Page
Praxis Impact Large Cap Value ETF (PRXV)
Rating:72Outperform
Price Target:
$33.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Johnson & Johnson and AbbVie, have shown strong year-to-date performance, supporting overall returns.
Broad Sector Diversification
The fund is spread across 11 sectors, including Financials, Health Care, and Technology, reducing reliance on any single industry.
Low Expense Ratio
With an expense ratio of 0.36%, the ETF is relatively cost-efficient compared to many actively managed funds.
Negative Factors
Overweight in U.S. Exposure
The ETF has 98.6% of its assets in U.S. companies, limiting diversification across global markets.
Underperforming Holdings
Some key positions, such as Procter & Gamble and ConocoPhillips, have lagged in year-to-date performance, potentially dragging down returns.
High Financial Sector Concentration
The fund allocates over 23% of its assets to the Financial sector, increasing vulnerability to sector-specific risks.
PRXV vs. SPDR S&P 500 ETF (SPY)
AUM55.51M
RegionNorth America
Expense Ratio0.36%
Beta0.68
IssuerPraxis
Inception DateApr 08, 2025
Dividend Yield0.72%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,691
30 Day Avg. Volume7,008
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
33.50Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering281
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PRXV Summary
The Praxis Impact Large Cap Value ETF (PRXV) is a fund that invests in large companies with strong value characteristics, while also focusing on socially responsible practices. It includes well-known companies like JPMorgan Chase and Johnson & Johnson, and covers a variety of sectors such as financials, healthcare, and technology. This ETF is ideal for investors who want to grow their money while supporting businesses that meet high ethical and environmental standards. However, since it primarily invests in large-cap stocks, its performance can be affected by overall market trends, which means it may go up or down with the economy.
How much will it cost me?The Praxis Impact Large Cap Value ETF (PRXV) has an expense ratio of 0.36%, which means you’ll pay $3.60 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed and focuses on socially responsible investing, which requires more research and oversight. It’s a good option if you value ethical considerations alongside financial returns.
What would affect this ETF?The PRXV ETF, with its focus on large-cap value stocks and ESG criteria, could benefit from increased investor interest in socially responsible investing and strong performance in sectors like financials and healthcare. However, it may face challenges if economic conditions weaken, particularly in North America, or if regulatory changes impact ESG-focused investments. Sector-specific risks, such as volatility in energy or technology, could also influence its future performance.
PRXV Top 10 Holdings
The Praxis Impact Large Cap Value ETF (PRXV) leans heavily on financials, with JPMorgan Chase providing steady long-term gains despite recent short-term softness. Health care names like Johnson & Johnson and AbbVie are rising stars, delivering robust performance and bolstering the fund’s ESG-focused strategy. On the flip side, consumer staples like Procter & Gamble are lagging, weighed down by macroeconomic challenges and slowing growth. With a strong U.S. focus and a tilt toward value-oriented sectors, PRXV’s positioning reflects a balanced yet socially responsible approach, though some holdings like ConocoPhillips may struggle amid sector volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 4.01% | $2.22M | $862.66B | 31.75% | 72 Outperform | |
| Johnson & Johnson | 2.28% | $1.26M | $453.94B | 26.98% | 78 Outperform | |
| Walmart | 2.11% | $1.16M | $816.58B | 21.71% | 75 Outperform | |
| Procter & Gamble | 1.99% | $1.10M | $339.99B | -10.43% | 74 Outperform | |
| AbbVie | 1.82% | $1.00M | $386.54B | 31.61% | 62 Neutral | |
| Home Depot | 1.76% | $970.82K | $368.72B | -7.15% | 75 Outperform | |
| Bank of America | 1.70% | $939.94K | $390.10B | 16.94% | 70 Outperform | |
| Coca-Cola | 1.59% | $877.43K | $303.35B | 13.31% | 78 Outperform | |
| Conocophillips | 1.37% | $755.16K | $109.03B | -18.03% | 75 Outperform | |
| Cisco Systems | 1.36% | $749.01K | $284.99B | 22.14% | 79 Outperform |
PRXV Technical Analysis
Positive
―
Price Trends
29.47
Positive
29.01
Positive
Market Momentum
0.02
Negative
59.75
Neutral
77.63
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRXV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 29.53, equal to the 50-day MA of 29.47, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 59.75 is Neutral, neither overbought nor oversold. The STOCH value of 77.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PRXV.
PRXV Peer Comparison
Comparison Results
Performance Comparison
PRXV
Praxis Impact Large Cap Value ETF
29.88
4.14
16.08%
MAVF
Matrix Advisors Value ETF
―
―
―
BLCV
BlackRock Large Cap Value ETF
―
―
―
FLCV
Federated Hermes MDT Large Cap Value ETF
―
―
―
ITAN
Sparkline Intangible Value ETF
―
―
―
CGVV
Capital Group U.S. Large Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents